These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8362887)

  • 1. Reimbursement and pharmacoeconomic perspectives in biotechnology.
    Bleecker GC
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S27-30. PubMed ID: 8362887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic management of biotechnology agents.
    Huber SL
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S31-3. PubMed ID: 8362888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State Medicaid and private payer reimbursement for telemedicine: An overview.
    Brown NA
    J Telemed Telecare; 2006; 12 Suppl 2():S32-9. PubMed ID: 16989672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; Medicare secondary payment--HCFA. General notice.
    Fed Regist; 1994 Jan; 59(20):4285-8. PubMed ID: 10133066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing biotechnology in a network-model health plan: a U.S. private payer perspective.
    Watkins JB; Choudhury SR; Wong E; Sullivan SD
    Health Aff (Millwood); 2006; 25(5):1347-52. PubMed ID: 16966732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reimbursement for outpatient biotech drugs--Part 2.
    Dasher T
    Am Pharm; 1993 Aug; NS33(8):24-5. PubMed ID: 8213466
    [No Abstract]   [Full Text] [Related]  

  • 10. Practice models used by pharmacists in rural Minnesota to obtain Medicare reimbursement.
    Larson TA; Uden DL; Hadsall RS
    J Am Pharm Assoc (Wash); 2000; 40(4):554-9. PubMed ID: 10932466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicaid reimbursement for alternative therapies.
    Steyer TE; Freed GL; Lantz PM
    Altern Ther Health Med; 2002; 8(6):84-8. PubMed ID: 12440844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician payment 2008 for interventionalists: current state of health care policy.
    Manchikanti L; Giordano J
    Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Payer-provider connectivity progress elusive but possible.
    Goldsmith J
    Healthc Financ Manage; 2008 Feb; 62(2):62-6. PubMed ID: 18309595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on the reimbursement paradox.
    Reaven NL; Rosenbloom J
    Crit Care Med; 2009 Jul; 37(7 Suppl):S285-9. PubMed ID: 19535960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; provider reimbursement determinations and appeals. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 May; 73(101):30189-267. PubMed ID: 18605405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Navigating payment pitfalls in managed care.
    Phillips B
    Healthc Financ Manage; 2003 Feb; 57(2):40-3. PubMed ID: 12602310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid-dependent hospitals and their patients: how have they fared?
    Dranove D; White WD
    Health Serv Res; 1998 Jun; 33(2 Pt 1):163-85. PubMed ID: 9618666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Billing third party payers for pharmaceutical care services.
    Poirier S; Buffington DE; Memoli GA
    J Am Pharm Assoc (Wash); 1999; 39(1):50-64; quiz 101-2. PubMed ID: 9990188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid: Medicaid: provider reimbursement--2005. End of Year Issue Brief.
    Johnson P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-11. PubMed ID: 16710912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMS adopts final regulations making major changes to provider reimbursement appeal procedures.
    Crosswhite CL
    J Med Pract Manage; 2008; 24(3):173-7. PubMed ID: 19146090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.